Lamictal Xr Chemical Structure (Lamictalxr Spl Graphic 01)
Lamictal Tablet, Film Coated, Extended Release
Product Images NDC 0173-0761
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Lamictal (NDC 0173-0761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lamictal Xr Figure 1 (Lamictalxr Spl Graphic 02)
Lamictal Xr Figure 2 (Lamictalxr Spl Graphic 03)
This appears to be a graph displaying the responder rate, improvement, and worsening percentages for a study of a drug called Lamictal XR compared to a placebo, based on the number of patients in each group. The graph shows a significant increase in the responder rate for Lamictal XR (labeled "V1005 'f") compared to the placebo, while the percentage of patients with worsening symptoms remained relatively similar between the two groups. The exact details of the study and what Lamictal XR is used for are not mentioned.*
25 mg Tablet (Lamictalxr Spl Graphic 04)
50 mg Tablet (Lamictalxr Spl Graphic 05)
100 mg Tablet (Lamictalxr Spl Graphic 06)
200 mg Tablet (Lamictalxr Spl Graphic 07)
250 mg Tablet (Lamictalxr Spl Graphic 08)
300 mg Tablet (Lamictalxr Spl Graphic 09)
Lamictal Xr 25mg 30 Count Label (Lamictalxr Spl Graphic 10)
A medication called LAMICTAL XR is available in extended-release tablets form with a concentration of 25mg. The package contains 30 tablets and comes with an accompanying medication guide. The manufacturer is GlaxoSmithKline, and it is made in India. The NDC number is 0173-0754-00, and the lot number is A146294. The rest of the text is not available.*
Lamictal Xr 50mg 30 Count Label (Lamictalxr Spl Graphic 11)
LAMICTAL XR is a medication containing lamotrigine, which comes in extended-release tablets that should be taken once a day. The medication should be stored at room temperature, as specified by USP Controlled Room Temperature. A specific NDC code is provided, which identifies the product dispensed. The accompanying medication guide should be given to each patient. Dosage information can be found in the prescribing information.*
Lamictal Xr 100 mg 30 Count Label (Lamictalxr Spl Graphic 12)
LAMICTAL XR is a medication used to treat seizures and bipolar disorder. It is taken once daily and is available in extended-release tablets. Patients should be given a Medication Guide with their prescription. The product is manufactured by GlaxoSmithKline in India. The NDC code is 0173-0756-00. Further prescribing information is available.*
Lamictal Xr 200mg 30 Count Label (Lamictalxr Spl Graphic 13)
This is the product label for Lamictal XR, a medication which comes in extended-release tablets. The label includes a warning to verify the correct product is being dispensed and to provide a medication guide to each patient. The package contains 30 tablets and there is a caution not to use if the printed safety seal is broken. The numbers 0173-0757-00 and NDC 0173-0757-00 are also included on the label. There is a number "2" and "5585" but it is not clear what they refer to.*
Lamictal Xr 250mg 30 Count Label (Lamictalxr Spl Graphic 14)
This is a description of a medication called LAMICTALXR. It is an extended-release tablet taken once a day and the active ingredient is LAMOTRIGINE. The package contains 30 tablets and it is recommended to dispense the accompanying Medication Guide to each patient. The product has a NDC number of 0173-0781-00.*
Lamictal Xr 300mg 30 Count Label (Lamictalxr Spl Graphic 15)
This is a medicine called Lamictal XR, which comes in extended-release tablets. The NDC (National Drug Code) for this medicine is 0173-0761-00, and each bottle contains 30 tablets. It is manufactured by GlaxoSmithKline in India. The medication guide should be given to each patient along with the medication. There is no meaningful explanation for the last line of the text.*
Lamictal Xr Kit 21 Count 25mg 7 Count 50mg Card (Lamictalxr Spl Graphic 16)
This text contains information about LAMICTALXR, which is an extended-release formulation of the drug lamotrigine, used to treat epilepsy and bipolar disorder. It provides information about dosing for patients taking valproate, as it may affect the dosing of LAMICTALXR. The medication comes in 25mg and 50mg tablets and the maintenance dose should be discussed with the physician before the fifth week of use. It states to verify product dispensed.*
Lamictal Xr Kit 14 Count 50mg 14 Count 100mg 7 Count 200mg Card (Lamictalxr Spl Graphic 17)
Lamictal XR is an extended-release tablet for patients taking specific medications for seizures. The patient titration kit includes 50mg, 100mg, and 200mg tablets to be taken over a 5-week period. Patients should consult with their physician before reaching the maintenance dose in week 5. Please provide the patient with a medication guide along with the prescription. The provided NDC number is 0173-0769-00.*
Lamictal Xr Kit 14 Count 25mg 14 Count 50mg 7 Count 100mg Card (Lamictalxr Spl Graphic 18)
LAMICTAL XR is a medication that comes in the form of extended-release tablets containing Lamotrigine. It is intended for patients who are taking carbamazepine, phenytoin, phenobarbital, primidone, or valproate. The tablets are available in three different strengths: 25 mg, 50 mg, and 100 mg. The caution advises verifying the product dispensed.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
